References
- Bolton Carter J. F. Reduction in thrombophlebitis by limiting duration of intravenous infusion. Lancet 1951; 2: 20–211. Bolton Carter J. F. Reduction in thrombophlebitis by limiting duration of intravenous infusion. Lancet 1951; 2: 20–21
- Crane C. Venous interruption for septic thrombophlebitis. New Eng. J. Med. 1960; 262: 947–9512. Crane C. Venous interruption for septic thrombophlebitis. New Eng. J. Med. 1960; 262: 947–951
- Doering R. B., Stemmer E. A., Connolly J. E. Complications of indwelling venous catheters. Amer. J. Surg. 1967; 114: 259–2663. Doering R. B., Stemmer E. A., Connolly J. E. Complications of indwelling venous catheters. Amer. J. Surg. 1967; 114: 259–266
- Eerola R., Pöntinen P. J. Prophylaxis of infusion thrombophlebitis. Ann. Chir. Gynaec. Fenn. 1964; 53: 519–5224. Eerola R., Pöntinen P. J. Prophylaxis of infusion thrombophlebitis. Ann. Chir. Gynaec. Fenn. 1964; 53: 519–522
- Elfving G., Saiku K. The effect of pH on the incidence of infusion thrombophlebitis. Lancet 1966; 1: 9535. Elfving G., Saiku K. The effect of pH on the incidence of infusion thrombophlebitis. Lancet 1966; 1: 953
- Gritsch H. J., Ballingek C. M. Value of indwelling catheters in intravenous therapy. J. Amer. med. Ass. 1959; 171: 281–2866. Gritsch H. J., Ballingek C. M. Value of indwelling catheters in intravenous therapy. J. Amer. med. Ass. 1959; 171: 281–286
- Hastbacka J., Tammisto T., Elsving G., Tiitinen P. Infusion thrombophlebitis: a clinical study based on 1, 048 cases. Acta Anaesth. Scand. 1965; 10: 9–307. Hastbacka J., Tammisto T., Elsving G., Tiitinen P. Infusion thrombophlebitis: a clinical study based on 1, 048 cases. Acta Anaesth. Scand. 1965; 10: 9–30
- Hillman L. S., Goodwin S. L., Sherman W. R. Identification and measurement of plasticizers in neo-natal tissues after umbilical catheters and blood products. New Eng. J. Med. 1975; 292: 3818. Hillman L. S., Goodwin S. L., Sherman W. R. Identification and measurement of plasticizers in neo-natal tissues after umbilical catheters and blood products. New Eng. J. Med. 1975; 292: 381
- Indor R. The dangers of indwelling polyethylene cannulae in deep veins. Lancet 1959; 1: 284–2869. Indor R. The dangers of indwelling polyethylene cannulae in deep veins. Lancet 1959; 1: 284–286
- Jones H. V., Craig D. B. Venous reactions to plastic intravenous cannulae -influence of cannula composition. Canad. anaesth. Soc. J. 1972; 19: 491–49710. Jones H. V., Craig D. B. Venous reactions to plastic intravenous cannulae -influence of cannula composition. Canad. anaesth. Soc. J. 1972; 19: 491–497
- Leading Article. A further hazard of intravenous therapy. Brit. med. J. 1975; 3: 26211. Leading Article. A further hazard of intravenous therapy. Brit. med. J. 1975; 3: 262
- Medical Research Council Report. Thrombophlebitis following intravenous infusions. A trial of plastic and rubber giving sets. Lancet 1957; 1: 595–59712. Medical Research Council Report. Thrombophlebitis following intravenous infusions. A trial of plastic and rubber giving sets. Lancet 1957; 1: 595–597
- Meyers L. Intravenous catheterisation. Amer. J. Nurs. 1945; 45: 930–93113. Meyers L. Intravenous catheterisation. Amer. J. Nurs. 1945; 45: 930–931
- Meyler F. L., Willebrands A. F., Duner D. The influence of polyvinyl chloride (P.V.C.) tubing on the isolated perfused rat heart. Circ. Res. 1960; 8: 4414. Meyler F. L., Willebrands A. F., Duner D. The influence of polyvinyl chloride (P.V.C.) tubing on the isolated perfused rat heart. Circ. Res. 1960; 8: 44
- Moncrief J. A. Femoral catheters. Ann. Surg. 1958; 147: 166–17215. Moncrief J. A. Femoral catheters. Ann. Surg. 1958; 147: 166–172
- Morris J. Thrombophlebitis following intravenous infusions. Lancet 1955; 1: 15416. Morris J. Thrombophlebitis following intravenous infusions. Lancet 1955; 1: 154
- Neuhof H., Seley G. P. Acute suppurative phlebitis complicated by septicaemia. Surgery 1974; 21: 831–84217. Neuhof H., Seley G. P. Acute suppurative phlebitis complicated by septicaemia. Surgery 1974; 21: 831–842
- Renerjii R. Thrombophlebitis following intravenous infusions. Lancet 1955; 1: 51418. Renerjii R. Thrombophlebitis following intravenous infusions. Lancet 1955; 1: 514
- Ross S. A. Infusion phlebitis. Selected factors. Nurs. Reg. 1972; 21: 31319. Ross S. A. Infusion phlebitis. Selected factors. Nurs. Reg. 1972; 21: 313
- Stein J. M., Pruitt B. A. Suppurative thrombophlebitis, a lethal iatrogenic disease. New Eng. J. Med. 1970; 282: 1452–145520. Stein J. M., Pruitt B. A. Suppurative thrombophlebitis, a lethal iatrogenic disease. New Eng. J. Med. 1970; 282: 1452–1455
- Thomas E. T., Evers W., Racz G. B. Post-infusion phlebitis. Anaesth. Analg. 1970; 49: 150–15921. Thomas E. T., Evers W., Racz G. B. Post-infusion phlebitis. Anaesth. Analg. 1970; 49: 150–159
- Valeri C. R., Contreras T. J., Feingold H., Sheibley R. H., Jaeger R. J. Accumulation of di-2-ethylhexylphthalate (DEHP) in whole blood, platelet concentrates and platelet-poor plasma: No. 1 Effect of DEHP on platelet survival and function. Environ. Health Perspect. 1973; 3: 10322. Valeri C. R., Contreras T. J., Feingold H., Sheibley R. H., Jaeger R. J. Accumulation of di-2-ethylhexylphthalate (DEHP) in whole blood, platelet concentrates and platelet-poor plasma: No. 1 Effect of DEHP on platelet survival and function. Environ. Health Perspect. 1973; 3: 103
- Zimmerman B. Intravenous tubing for parenteral therapy. Science 1945; 101: 566–56823. Zimmerman B. Intravenous tubing for parenteral therapy. Science 1945; 101: 566–568